U.S. FDA approves biosimilar version of cancer drug Avastin

(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc's biosimilar version of Roche Holding AG's cancer drug Avastin.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news